Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Promising preclinical data reported for argatroban in rat ischemic stroke model

May 10, 2001

Inhibitors of factor Xa under development at Cor Therapeutics

May 8, 2001

Novel P2T receptor antagonists identified at AstraZeneca as potential antithrombotics

May 8, 2001

Antithrombotic activity of agkistin related to platelet gpIb antagonism

May 8, 2001

Reviparin compared to heparin in deep vein thrombosis

May 4, 2001

Protein enters preclinical development for acute thrombosis at Myriad Genetics

May 3, 2001

Antithrombotic pentasaccharide assigned fast track review by FDA

May 3, 2001

3-D's new serine protease inhibitors and their use disclosed in recent patent

May 2, 2001

Potent anticoagulant activity of ART-123 associated with reduced effects on hemostasis

April 24, 2001

Cor discloses potent, selective factor Xa inhibitors

April 20, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...